Giulia Marvaso, Assistant Professor in the Department of Oncology and Hemato-Oncology at the University of Milan and Radiation Oncologist at IEO Milan, shared on X about a recent paper published on ScienceDirect:
“New Editorial in EU platinum
EMBARK puts ARPIs in the spotlight, but where does RT stand in high-risk BCR?
Perspectives, open questions, insights on imaging, MDT and integration.”
Title: Should We Embark on “EMBARK”? Reassessing the Role of Radiotherapy and Androgen Receptor Pathway Inhibitors in the Era of Next-generation Imaging
Authors: Giulia Marvaso, Giulio Francolini, Vérane Achard, Alfonso Gomez-Iturriaga, Finbar Slevin, Thomas Zilli, Piet Ost
More from EMBARK on OncoDaily.